CUE - Cue Biopharma, Inc.
0.8363
0.054 6.409%
Share volume: 327,586
Last Updated: 04-23-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.78
0.05
0.07%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-09-2023 | 08-08-2023 | 11-03-2023 | 03-28-2024 | 05-09-2024 | 08-14-2024 | 11-14-2024 | |
| Cash flow financing | 388.000 K | 2.101 M | 4.589 M | 4.782 M | 2.354 M | -1.000 M | 9.821 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 2.354 M | 1.000 M | 0.000 | |
| Cash flow | -10.833 M | -10.371 M | -7.799 M | -10.958 M | -7.485 M | -11.000 M | 2.392 M | |
| Net income | -13.109 M | -13.185 M | -11.005 M | -13.434 M | -12.347 M | -10.171 M | -8.660 M | |
| Depreciation | 177.000 K | 136.000 K | 130.000 K | 113.000 K | 99.000 K | 99.000 K | 101.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 196.000 K | 1.135 M | 1.661 M | 1.698 M | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 15.002 M | 5.000 M | 5.000 M | 0.000 | -55.000 K | -10.000 K | 98.000 K | |
| Net Borrowings | -49.854 M | -41.756 M | -39.479 M | -35.061 M | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 55.000 K | 10.000 K | -98.000 K | |
| Cash Change | 66.199 M | 57.889 M | 54.691 M | 48.514 M | -7.485 M | -11.000 M | 2.392 M |
